Farrow Financial Inc. Purchases Shares of 78,070 Teladoc Health, Inc. (NYSE:TDOC)

Farrow Financial Inc. acquired a new position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 78,070 shares of the health services provider's stock, valued at approximately $1,682,000.

Several other hedge funds have also recently made changes to their positions in TDOC. Commonwealth Equity Services LLC boosted its position in Teladoc Health by 5.7% during the 3rd quarter. Commonwealth Equity Services LLC now owns 80,934 shares of the health services provider's stock valued at $1,505,000 after acquiring an additional 4,344 shares in the last quarter. Raymond James & Associates boosted its position in shares of Teladoc Health by 0.9% during the third quarter. Raymond James & Associates now owns 228,238 shares of the health services provider's stock valued at $4,243,000 after purchasing an additional 2,029 shares in the last quarter. Mackenzie Financial Corp grew its stake in Teladoc Health by 83.7% in the third quarter. Mackenzie Financial Corp now owns 30,843 shares of the health services provider's stock worth $570,000 after purchasing an additional 14,050 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Teladoc Health by 8.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 50,903 shares of the health services provider's stock worth $946,000 after purchasing an additional 4,129 shares in the last quarter. Finally, Triumph Capital Management purchased a new position in Teladoc Health during the third quarter valued at $320,000. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Stock Performance

Teladoc Health stock traded up $0.08 during midday trading on Thursday, hitting $12.90. The stock had a trading volume of 4,005,408 shares, compared to its average volume of 4,895,826. Teladoc Health, Inc. has a 52-week low of $11.88 and a 52-week high of $30.41. The company has a market capitalization of $2.19 billion, a PE ratio of -9.15 and a beta of 0.97. The firm's fifty day moving average is $14.03 and its two-hundred day moving average is $17.23. The company has a current ratio of 3.82, a quick ratio of 3.74 and a debt-to-equity ratio of 0.67.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The business had revenue of $646.13 million during the quarter, compared to analysts' expectations of $637.31 million. During the same quarter in the previous year, the company posted ($0.37) EPS. The company's quarterly revenue was up 2.7% on a year-over-year basis. On average, research analysts forecast that Teladoc Health, Inc. will post -1.04 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on TDOC. Stifel Nicolaus lowered their target price on shares of Teladoc Health from $21.00 to $16.00 and set a "hold" rating for the company in a report on Friday, April 26th. Bank of America cut their price objective on shares of Teladoc Health from $16.50 to $13.50 and set a "neutral" rating on the stock in a research report on Tuesday. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research report on Friday, April 26th. Royal Bank of Canada cut their target price on Teladoc Health from $25.00 to $18.00 and set an "outperform" rating on the stock in a research note on Friday, April 26th. Finally, Truist Financial reduced their price objective on Teladoc Health from $23.00 to $17.00 and set a "hold" rating for the company in a report on Wednesday, March 6th. Thirteen research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $18.41.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Daniel Trencher sold 6,780 shares of Teladoc Health stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $98,445.60. Following the sale, the insider now owns 28,192 shares of the company's stock, valued at approximately $409,347.84. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, insider Daniel Trencher sold 6,780 shares of Teladoc Health stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $98,445.60. Following the completion of the transaction, the insider now owns 28,192 shares in the company, valued at $409,347.84. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Andrew Turitz sold 6,190 shares of the company's stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $89,878.80. Following the sale, the executive vice president now owns 39,429 shares in the company, valued at $572,509.08. The disclosure for this sale can be found here. Insiders sold 138,368 shares of company stock valued at $1,989,227 in the last 90 days. Insiders own 0.95% of the company's stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.